Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice

Oligonucleotides

Volumn 16, Issue 4, 2006, Pages 365-374

  Sun, Yuning ^a   Lin, Ruxian ^a   Dai, Jinming ^a   Jin, Dazhi ^a   Wang, Sheng Qi ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INHIBITOR; CASPASE 3; FLUOROURACIL; MESSENGER RNA; REAGENT; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; GENE OVEREXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CASPASE 3; CELL DIVISION; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE THERAPY; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 33846028212     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.16.365     Document Type: Article

References (44)

1. ADIDA, C., HAIOUS, C., GAULARD, P., LEPAGE, E., MORE P., BRIERE, J., DOMBRET, H., REYES, F., DIEBOLD, J., GISSELBRECHT, C., SALLES, G., ALTIERI, D.C., and MOLINA, T.J. (2000). Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96, 1921-1925.
2. ALTIERI, D.C. (2003a). Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3, 46-54.
3. ALTIERI, D.C. (2003b). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22, 8581-8589.
4. ALTIERI, D.C., and MARCHISIO, P.C. (1999). Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab. Invest. 79, 1327-1333.
5. AMBROSINI, G., ADIDA, C., and ALTIERI, D.C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921.
6. ANDREWS, G.K., DZIADEK, M., and TAMAOKI, T. (1982). Expression and methylation of the mouse alpha-fetoprotein gene in embryonic, adult, and neoplastic tissues. J. Biol. Chem. 257, 5148-5153.
7. ARMENGOL, C., TARAFA, G., BOIX, L., SOLE, M., QUERALT, R., COSTA, D., BACHS, O., BRUIX, J., and GAPELLA, G. (2004). Orthotopic implantation of human hepatocellular carcinoma in mice: Analysis of tumor progression and establishment of the BCLC-9 cell line. Clin. Cancer Res. 10, 2150-2157.
8. BELTRAMI, E., PLESCIA, J., WILKINSON, J.C., DUCKETT, C.S., and ALTIERI, D.C. (2004). Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 279, 2077-2084.
9. BRUIX, J., and LLOVET, J.M. (2002). Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 5, 519-524.
10. CHALK, A.M., and SONNHAMMER, E.L. (2002). Computational antisense oligo prediction with a neural network model. Bioinformatics 18, 1567-1575.
11. CHAO, J.I., KUO, P.C., and HSU T.S. (2004). Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J. Biol. Chem. 279, 20267-20276.
12. CHENG, S.Q., WANG, W.L., YAN, W., LI, Q.L., WANG, L., and WANG, W.Y. (2005). Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. World J. Gastroenterol. 11, 756-759.
13. CHOU, S.F., HSU, W.L., HWANG, J.M., and CHEN, C.Y. (2002). Production of monoclonal and polyclonal antibodies against human alphafetoprotein, a hepatocellular tumor marker. Hybrid Hybridomics 21, 301-305.
14. COMA, S., NOE, V., LAVARINO, C., ADAN, J., RIVAS, M., LOPEZ-MATAS, M., PAGAN, R., MITJANS, F., VILARO, S., PIULATS, J., CIUDAD, C.J. (2004). Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis. Oligonucleotides 4, 100-113.
15. CURTIN, N.J., HARRIS, A.L., JAMES, O.F., and BASSENDINE, M.F. (1986). Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717. Br. J. Cancer 53, 361-368.
16. DAI, D.J., LU, C.D., LAI, R.Y., GUO, J.M., MENG, H., CHEN, W.S., and GU, J. (2005). Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells. World J. Gastroenterol. 11, 193-199.
17. DIAS, N., and STEIN, C.A. (2002). Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 1, 347-355.
18. DUDICH, E., SEMONKOVA, L., GORBATOVA, E., DUDICH, I., KHROMYH, L., TATULOV, E., GRECHKO, G., and SUKHIKH, G. (1998). Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumor Biol. 19, 30-40.
19. FIELDS, A.C., COTSONIS, G., SEXTON, D., SANTOIANNI, R., and COHEN, C. (2004). Survivin expression in hepatocellular carcinoma: Correlation with proliferation, prognostic parameters, and outcome. Mod. Pathol. 17, 1378-1385.
20. FU, X.Y., BESTERMAN, J.M., MONOSOV, A., and HOFFMAN, R.M. (1991). Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. 88, 9345-9349.
21. FUKUDA, S., and PELUS, L.M. (2006). Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer ther. 5, 1087-1098.
22. IKEGUCHI, M., UETA T., YAMANE, Y., HIROOKA, Y., and KAIBARA, N. (2000). Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin. Cancer Res. 8, 3131-3136.
23. ITO, T., SHIRAKI, K., SUGIMOTO, K., YAMANAKA, T., FUJIKAWA, K., ITO, M., TAKASE, K., MORIYAMA, M., KAWANO, H., HAYASHIDA, M., NAKANO, T., and SUZUKI, A. (2000). Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31, 1080-1085.
24. KAIBORI, M., MATSUI, Y., YANAGIDA, H., YOKOIGAWA, N., KWON, A.H., and KAMIYAMA, Y. (2004). Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: Important prognostic factor for recurrent hepatocellular carcinoma. World J. Surg. 28, 702-707.
25. KANNANGAI, R., WANG, J., LIU Q.Z., SAHIN, F., and TORBENSON, M. (2005). Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. Int. J. Gastrointest Cancer 35, 53-60.
26. KATYAL, S., OLIVER III, J.H. PETERSON, M.S., FERRIS, J.V., CARR, B.S., and BARON, R.L. (2000). Extrahepatic metastasis of hepatocellular carcinoma. Radiology 216, 698-703.
27. LEE, W.C., JENG, L.B., and CHEN, M.F. (2002). Estimation of prognosis after hepatectomy for hepatocellular carcinoma. Br. J. Surg. 89, 311-316.
28. LI, F., ACKERMANN, E.J., BENNETT, C.F., ROTHERMEL, A.L., PLESCIA, J., TOGNIN, S., VILLA, A., MARCHISIO, P.C., and ALTIERI, D.C. (1999). Pleiotropic cell division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1, 461-466.
29. LI, F., AMBROSINI, G., CHU, E.Y., PLESCIA, J., TOGNIN, S., MARDHISIO, P.C., and ALTIERI, D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (Lond) 396, 580-583.
30. MONZO, M., ROSELL, R., FELIP, E., ASTUDILLO, J., SANCHEZ, J.J., MAESTRE, J., MARTIN, C., FONT, A., BARNADAS, A., and ABAD, A. (1999). A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17, 2100-2104.
31. MORINAGA, S., NAKAMURA, Y., ISHIWA, N., YOSHIKAWA, T., NOGUCHI, Y., YAMAMOTO, Y., RINO, Y., IMADA, T., TAKANASHI, Y., AKAIKE, M., SUGIMASA, Y., and TAKEMIYA, S. (2004). Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. Oncol. Rep. 12, 1189-1194.
32. OLIE, R.A., SIMOES-WUST A.P., BAUMANN, B., LEECH, S.H., FABBRO, D., STAHEL, R.A., and ZANGEMEISTER-WITTKE, U. (2000). A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res. 60, 2805-2809.
33. PENG, S.Y., CHEN W.J., LAI, P.L., JENG, Y.M., SHEU, J.C., and HSU, H.C. (2004). High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int. J. Cancer 112, 44-50.
34. REED, J.C., and BISCHOFF, J.R. (2000). BIRinging chromosomes through cell division and survivin the experience. Cell 102, 545-548.
35. RODEL, F., HOFFMANN, J., DISTEL, L., HERRMANN, M., NOISTERNIG, T., PAPADOPOULOS, T., SAUER, R., and RODEL, C. (2005). Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res. 65, 4881-4887.
36. SCHERER, L.J., and ROSSI J.J. (2003). Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21, 1457-1465.
37. SHARMA, H., SEN, S., LO MUZIO, L., MARIGGIO, A., and SINGH, N. (2005). Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol. Ther. 4, 720-727.
38. SONG, B.C., SUH D.J., YANG, S.H., LEE, H.C., CHUNG, Y.H., SUNG, K.B., and LEE, Y.S. (2002). Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. J. Clin. Gastroenterol. 35, 398-402.
39. TARAFA, G., VILLANUEVA, A., FARRE, L., RODRIGUEZ, J., MUSULEN, E., REYES, G., SEMINAGO, R., OLMEDO, E., PAULES, A.B., PEINADO, M.A., BACHS, O., and CAPELLA, G. (2000). DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Oncogene 19, 546-555.
40. TILGHMAN, S. M. and BELAYEW, A. (1982). Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc. Natl. Acad. Sci. USA 79, 5254-5257.
41. WANG, X.W., and XIE H. (1999). Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci. 64, 17-23.
42. XIA, C., XU, Z., YUAN, X., UEMATSU, K., YOU, L., LI, K., LI, L., MCCORMICK, F., and JABLONS, D.M. (2002). Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther. 1, 687-694.
43. YAO, X., HU, J.F., DANIELS, M., YIEN, H., LU, H., SHARAN, H., ZHOU, X., ZENG, Z., LI, T., YANG, Y., and HOFFMAN, A.R. (2003). A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. Clin. Cancer Res. 9, 2719-2726.
44. ZUKER, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415.